Evidence Summary on AstraZeneca COVID-19 vaccine as Second Booster/ Fourth Dose for the prevention of COVID-19
HTAC Guidance: Limited evidence of improved protection from 2nd booster dose among healthy individuals aged 18-49 years
HTAC Recommendation on the Second Booster of COVID-19 vaccines for the prevention of COVID-19 among individuals aged 50 years old and older and individuals with comorbidities aged 18 to 49 years old
DOH, HTAC GUIDANCE ON COVID-19 BOOSTERS AND FOURTH DOSE FOR HEALTHCARE WORKERS, SENIOR CITIZENS, AND THE IMMUNOCOMPROMISED POPULATION
